Recovery from severe arsenic-induced peripheral neuropathy with 2,3-dimercapto-1-propanesulphonic acid

Journal of Toxicology - Clinical Toxicology

Volumn 38, Issue 7, 2000, Pages 777-780

  Wax, P M ^a   Thornton, C A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CHELATING AGENT; DIMERCAPROL; SUCCIMER; UNITHIOL;

ADULT; ARSENIC POISONING; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CHILL; DIURESIS; EXTUBATION; FEMALE; HUMAN; HYPERTENSION; MUSCLE WEAKNESS; PERIPHERAL NEUROPATHY; PRURITUS; QUADRIPLEGIA; SENSORY DYSFUNCTION; URINE LEVEL;

ADULT; ARSENIC; ARSENIC POISONING; CHELATING AGENTS; FEMALE; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES; UNITHIOL;

EID: 0034526778     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-100102391     Document Type: Article

References (9)

1. Peripheral neuropathy caused by arsenical intoxication
2. BAL increases the arsenic-74 content of rabbit brain
3. Effect of oral treatment with BAL, DMPS or DMSA. Arsenic in organs of mice injected with arsenic trioxide
4. Human studies with the chelating agents, DMPS and DMSA
5. Synthese und eigenschaften der dimerkaptoderivate von alkansulfonsauren
6. DMSA and DMPS - Water soluble antidotes for heavy metal poisoning
7. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate
8. Polyneuropathy due to acute arsenic intoxication: Biopsy studies
9. Acute arsenic poisoning: Absence of polyneuropathy after treatment with 2,3-dimercatopropanesulfphonate (DMPS)